Skip to content

Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms

Relationship Between Metabolic Profiles and Chronic Diseases and Neoplasms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06524037
Enrollment
2000
Registered
2024-07-29
Start date
2022-01-01
Completion date
2032-12-31
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Diseases

Brief summary

Metabolic disorders are involved in the occurrence and development of a variety of chronic diseases and tumors. There are many common risk factors between chronic diseases and tumors. However, the mechanisms of chronic diseases and tumors caused by metabolic disorders are not completely clear. By observing the relationship between metabolic indexes and chronic diseases and tumors, the investigators intend to explore the possible mechanisms of metabolic status participating in the occurrence and development of chronic diseases and tumors.

Detailed description

Metabolic disorders are involved in the occurrence and development of a variety of chronic diseases and tumors, for example, metabolic diseases (hypertension, diabetes, dyslipidemia, obesity, etc.) can mediate the progression of chronic diseases such as heart failure and ischemic encephalopathy. Obesity can increase the risks of endometrial cancer, esophageal cancer, stomach cancer, etc. There are many common risk factors between chronic diseases and tumors, such as age, sex, smoking, genetics, obesity, unhealthy diet and lack of exercise. However, the mechanisms of chronic diseases and tumors caused by metabolic disorders are not completely clear. By observing the relationship between metabolic indexes and chronic diseases and tumors, the investigators intend to explore the possible mechanisms of metabolic status participating in the occurrence and development of chronic diseases and tumors.

Interventions

None listed

Sponsors

First Affiliated Hospital of Chongqing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years

Inclusion criteria

* adult aged ≥18 years old * Completed health screening

Exclusion criteria

* aged \<18 years old * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
metabolic disorderthrough study completion, an average of 1 yearThe degree of metabolic disorder liking the levels of glycolipids
Chronic diseasethrough study completion, an average of 1 yearThe occurrence of chronic disease
Tumorthrough study completion, an average of 1 yearThe occurrence of tumor

Countries

China

Contacts

Primary ContactQin Duan, doctor
570549500@qq.com+8618623349865

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026